SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test (Nasopharyngeal Swab)
The SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A and Influenza B virus antigens in nasopharyngeal swab specimens from individuals with suspected SARS-CoV-2/Influenza infection in conjunction with clinical presentation and the results of other laboratory tests.
Product Features
Fast results
Easy visual interpretation
Simple operation, no equipment required
High accuracy
Product Specification
PrincipleChromatographic Immunoassay
FormatCassette
SpecimenNasopharyngeal Swab
CertificateCE
Reading Time15 minutes
Pack20 T
Storage Temperature2-30°C
Shelf Life2 Years
Sensitivity97.6%(COVID-19) / 94.7%(Influenza A) / 93.0%(Influenza B)
Specificity99.7%(COVID-19) / 98.2%(Influenza A) / 97.7%(Influenza B)
Accuracy99.1%(COVID-19) / 97.7%(Influenza A) / 97.0%(Influenza B)
Ordering Information
Cat. No.
Product
Specimen
Pack
Cut-Off
ISIC-525
SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test